These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28202)

  • 1. The effect of rubidium in schizophrenia.
    Chouinard G; Annable L
    Commun Psychopharmacol; 1977; 1(4):373-83. PubMed ID: 28202
    [No Abstract]   [Full Text] [Related]  

  • 2. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
    Villeneuve A; Dogan K; Lachance R; Drolet A
    Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential value of penfluridol and pipothiazine palmitate.
    Gallant DM
    Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical effect of L-dopa on schizophrenia.
    Ogura C; Kishimoto A; Nakao T
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):308-18. PubMed ID: 9266
    [No Abstract]   [Full Text] [Related]  

  • 7. Celecoxib augmentation of continuously ill patients with schizophrenia.
    Rapaport MH; Delrahim KK; Bresee CJ; Maddux RE; Ahmadpour O; Dolnak D
    Biol Psychiatry; 2005 Jun; 57(12):1594-6. PubMed ID: 15953498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia.
    Whiteford HA; Stedman TJ; Welham J; Csernansky JG; Pond SM
    J Clin Psychopharmacol; 1992 Oct; 12(5):337-40. PubMed ID: 1362205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pipotiazine palmitate: a new depot neuroleptic.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):276-80. PubMed ID: 236151
    [No Abstract]   [Full Text] [Related]  

  • 10. Simplified symptom registration in psychiatric trials: a statistical approach.
    Hansen V; Hagen AS; Lehmann EH; Astrup C
    Acta Psychiatr Scand; 1974; 50(5):492-5. PubMed ID: 4156625
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of phenothiazines on anxiety and cognition in schizophrenia.
    Meadow A; Donlon PT; Blacker KH
    Dis Nerv Syst; 1975 Apr; 36(4):203-8. PubMed ID: 234827
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled study of tryptophan-benserazide in schizophrenia.
    Chouinard Q; Annable L; Young SN; Sourkes TL
    Commun Psychopharmacol; 1978; 2(1):21-31. PubMed ID: 350483
    [No Abstract]   [Full Text] [Related]  

  • 13. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loxapine succinate: a controlled double-blind study in schizophrenia.
    Charalampous KD; Freemesser GF; Malev J; Ford K
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):829-37. PubMed ID: 4217251
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Winter K; Fullerton AG; Hussain K; Tarlo L
    Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients.
    Jain RC; Ananth JV; Lehmann HE; Ban TA
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):585-9. PubMed ID: 241609
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Butaclamol in the treatment of schizophrenia--a comparison of two treatment methods.
    Imaz F; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1976 Jan; 12(1):31-4. PubMed ID: 1826
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the effectiveness of antidepressant drugs.
    Smith A; Traganza E; Harrison G
    Psychopharmacol Bull; 1969 Mar; ():Suppl:1-53. PubMed ID: 4898337
    [No Abstract]   [Full Text] [Related]  

  • 20. [Report on an open investigation on bromperidol, a neuroleptic of the butyrophenone series].
    Fleischhauer J
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():30-7. PubMed ID: 35476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.